12-132649460-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_006231.4(POLE):​c.3851G>A​(p.Arg1284Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,611,964 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1284G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00065 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 2 hom. )

Consequence

POLE
NM_006231.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:12

Conservation

PhyloP100: 1.88

Publications

6 publications found
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
POLE Gene-Disease associations (from GenCC):
  • POLE-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • facial dysmorphism-immunodeficiency-livedo-short stature syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • IMAGe syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03191352).
BP6
Variant 12-132649460-C-T is Benign according to our data. Variant chr12-132649460-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 240480.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00065 (99/152322) while in subpopulation NFE AF = 0.0011 (75/68026). AF 95% confidence interval is 0.000902. There are 0 homozygotes in GnomAd4. There are 48 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006231.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
NM_006231.4
MANE Select
c.3851G>Ap.Arg1284Gln
missense
Exon 31 of 49NP_006222.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
ENST00000320574.10
TSL:1 MANE Select
c.3851G>Ap.Arg1284Gln
missense
Exon 31 of 49ENSP00000322570.5
POLE
ENST00000535270.5
TSL:1
c.3770G>Ap.Arg1257Gln
missense
Exon 30 of 48ENSP00000445753.1
POLE
ENST00000537064.5
TSL:1
n.*3602G>A
non_coding_transcript_exon
Exon 31 of 49ENSP00000442578.1

Frequencies

GnomAD3 genomes
AF:
0.000644
AC:
98
AN:
152204
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00110
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000629
AC:
151
AN:
240136
AF XY:
0.000605
show subpopulations
Gnomad AFR exome
AF:
0.000208
Gnomad AMR exome
AF:
0.000378
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000558
Gnomad FIN exome
AF:
0.000145
Gnomad NFE exome
AF:
0.00120
Gnomad OTH exome
AF:
0.000338
GnomAD4 exome
AF:
0.00123
AC:
1795
AN:
1459642
Hom.:
2
Cov.:
32
AF XY:
0.00116
AC XY:
839
AN XY:
726120
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33468
American (AMR)
AF:
0.000402
AC:
18
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86232
European-Finnish (FIN)
AF:
0.000252
AC:
13
AN:
51618
Middle Eastern (MID)
AF:
0.00254
AC:
14
AN:
5520
European-Non Finnish (NFE)
AF:
0.00151
AC:
1680
AN:
1111940
Other (OTH)
AF:
0.000796
AC:
48
AN:
60308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
103
206
308
411
514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000650
AC:
99
AN:
152322
Hom.:
0
Cov.:
33
AF XY:
0.000644
AC XY:
48
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41578
American (AMR)
AF:
0.000327
AC:
5
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00110
AC:
75
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00199
Hom.:
2
Bravo
AF:
0.000763
ESP6500AA
AF:
0.000230
AC:
1
ESP6500EA
AF:
0.00106
AC:
9
ExAC
AF:
0.000620
AC:
75
EpiCase
AF:
0.00174
EpiControl
AF:
0.000948

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
5
not provided (7)
-
3
3
not specified (6)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Carcinoma of colon (1)
-
-
1
POLE-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.074
T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.45
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.0079
T
MetaRNN
Benign
0.032
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.9
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.026
Sift
Benign
0.46
T
Sift4G
Benign
0.63
T
Polyphen
0.0010
B
Vest4
0.24
MVP
0.18
MPC
0.22
ClinPred
0.023
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.038
gMVP
0.20
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149462407; hg19: chr12-133226046; COSMIC: COSV100268917; COSMIC: COSV100268917; API